Combining Idecalcitol, Whey Protein, and Exercise to Treat Sarcopenia
Official title: Clinical Intervention of Idecalcitol Combined With Whey Protein Powder and Exercise for Sarcopenia:a RCT Trial
Run by Zhejiang Provincial People's Hospital · NCT06537115 · Data updated 2026-11-12
This study is testing whether combining a vitamin, whey protein, and exercise can help people with sarcopenia build muscle and improve their strength.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 450 (estimated) |
| Sponsor | Zhejiang Provincial People's Hospital Academic / other |
| Locations | 5 sites (Hangzhou, Zhejiang and 4 other locations) |
| Status | Recruiting |
| Started | June 16, 2024 |
| Main results expected | May 31, 2026 |
| Study ends | May 31, 2027 |
| Registry record updated | August 5, 2024 |
| Trial ID | NCT06537115 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 30 and above who meet the diagnostic criteria for sarcopenia and are able to participate in a comprehensive intervention plan.
✕Probably not a fit
Patients with severe cardiovascular issues, active malignancies, or other significant health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of idecalcitol combined with whey protein powder and exercise on patients with sarcopenia. Participants are randomly assigned to a control group receiving standard interventions or to experimental groups receiving additional whey protein or both whey protein and idecalcitol. The trial lasts for 24 weeks, focusing on improving muscle mass and function in individuals diagnosed with sarcopenia. The study aims to assess the efficacy of these combined interventions in enhancing patient outcomes.
Why it matters
Potential benefit: If successful, this approach could significantly improve muscle strength and overall health in patients suffering from sarcopenia.
How similar studies have gone: Other studies have shown promising results with similar interventions for sarcopenia, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
* Age 30 or above;
* Meeting the diagnostic criteria for sarcopenia according to the definition of AWGS; ③ Able to walk, willing to accept a comprehensive intervention plan, and guarantee to complete the treatment course; ④ Both patients and their families agree to participate in this study and sign the informed consent form.
Exclusion Criteria:
* Resting systolic blood pressure \> 200 mmHg or resting diastolic blood pressure \> 100 mmHg;
* Severe heart disease: moderate to severe aortic valve stenosis, acute pericarditis, acute myocarditis, myocardial infarction, uncontrollable arrhythmia;
* Acute stroke within the past 2 years;
* Severe airway obstruction;
* Lower limb fractures in the past 1 year or upper limb fractures in the past 6 months;
* Hypercalcemia (corrected albumin serum calcium \> 2.60 mmol/L);
* Active malignant tumors; ⑧ Chronic kidney disease stages 5;
* Mental illness or severe cognitive impairment;
* Long-term immobilization; ⑪ Other diseases that may interfere with the evaluation of muscle mass, muscle strength, and physical function; ⑫ Unable to cooperate with treatment due to other reasons; ⑬ Life expectancy less than 6 months.
Where it's running
-
The First People's Hospital of Chun'an County
Hangzhou, Zhejiang, China Recruiting -
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China Recruiting -
Huzhou Nanxun District People's Hospital
Huzhou, Zhejiang, China Recruiting -
Xianju People's Hospital
Taizhou, Zhejiang, China Recruiting -
Dinghai Central Hospital of Zhoushan City
Zhoushan, Zhejiang, China Recruiting
Study contacts
- Principal investigator: Jianfang Ni, bachelor — Zhejiang Provincial People's Hospital
- Study coordinator: Jianfeng Tu, Doctor
- Email: tutu5800@163.com
- Phone: +86 15925669920
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sarcopenia in Patients After Cardiac Surgery
This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.
-
Bone marrow mesenchymal stem cell injection for sarcopenia
This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.
-
GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes
This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.
-
Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis
We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Lower-limb rehabilitation robot training with nutrition education for sarcopenia
In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.